| Literature DB >> 34179242 |
Shima Tavakol1,2, Fereshteh Azedi1,3, Elham Hoveizi4, Jafar Ai5, Mohammad Taghi Joghataei1,3.
Abstract
Human endometrial stem cell/stromal cells (hEnSCs) are isolated from endometrium or menstrual blood and are recognized as a valuable cell type in tissue engineering and cell therapy. Furthermore, hEnSCs, which have CD90 (a mesenchymal marker), CD105 (endoglin), CD44, CD146 (endometrial stem cell markers) and lack CD31 (Endothelial marker), CD34 (hematopoietic marker) and CD133 on the cell surface, are a new source of mesenchymal stem/stromal cells. Additionally, these cells can be encapsulated into self-assembling peptide nanofibers as a 3D scaffold for applications in the treatment of neurodegenerative diseases. Here, we describe a protocol to isolate hEnSCs from endometrium or menstrual blood.Entities:
Keywords: 3D cell culture; Cell isolation; Endometrial stem cell; Endometrial stromal cell; Menstrual blood; Neural differentiation; Self-assembling peptide nanofiber
Year: 2018 PMID: 34179242 PMCID: PMC8203874 DOI: 10.21769/BioProtoc.2693
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325